Cargando…

Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study

INTRODUCTION: Approximately 130 000 infants acquire HIV annually despite global maternal antiretroviral therapy scale-up. We evaluated the potential clinical impact and cost-effectiveness of offering long-acting, anti-HIV broadly neutralizing antibody (bNAb) prophylaxis to infants in three distinct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alba, Christopher, Malhotra, Shelly, Horsfall, Stephanie, Barnhart, Matthew E., Bekker, Adrie, Chapman, Katerina, Cunningham, Coleen K., Fast, Patricia E., Fouda, Genevieve G., Freedberg, Kenneth A., Goga, Ameena, Ghazaryan, Lusine R., Leroy, Valériane, Mann, Carlyn, McCluskey, Margaret M., McFarland, Elizabeth J., Muturi-Kioi, Vincent, Permar, Sallie R., Shapiro, Roger, Sok, Devin, Stranix-Chibanda, Lynda, Weinstein, Milton C., Ciaranello, Andrea L., Dugdale, Caitlin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659508/ https://www.ncbi.nlm.nih.gov/pubmed/37986879 http://dx.doi.org/10.1101/2023.11.06.23298184

Ejemplares similares

Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings
por: Dugdale, Caitlin M., et al.
Publicado: (2023)

Accelerating HIV vaccine development through meaningful engagement of local scientists and communities
por: Chinyenze, Kundai, et al.
Publicado: (2023)

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
por: Ciaranello, Andrea L, et al.
Publicado: (2011)

Antibodies for HIV prevention: the path forward
por: Malhotra, Shelly, et al.
Publicado: (2023)

Recent progress in immune‐based interventions to prevent HIV‐1 transmission to children
por: Voronin, Yegor, et al.
Publicado: (2017)

Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV
por: Ruel, Theodore, et al.
Publicado: (2023)

Unmasking the vulnerabilities of uninfected children exposed to HIV
por: Ramokolo, Vundli, et al.
Publicado: (2019)

Optimal breastfeeding durations for HIV‐exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk
por: Mallampati, Divya, et al.
Publicado: (2018)

The Role of Maternal HIV Envelope-Specific Antibodies and Mother-to-Child Transmission Risk
por: Douglas, Ayooluwa O., et al.
Publicado: (2017)

Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa
por: Fatti, Geoffrey, et al.
Publicado: (2017)

The Presence and Anti-HIV-1 Function of Tenascin C in Breast Milk and Genital Fluids
por: Mansour, Robin G, et al.
Publicado: (2016)

Factors associated with access to HIV care and treatment in a prevention of mother to child transmission programme in urban Zimbabwe
por: Muchedzi, Auxilia, et al.
Publicado: (2010)

Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward
por: Torres-Rueda, Sergio, et al.
Publicado: (2023)

Harnessing early life immunity to develop a pediatric HIV vaccine that can protect through adolescence
por: Goswami, Ria, et al.
Publicado: (2020)

Trends and predictors of mother-to-child transmission of HIV in an era of protocol changes: Findings from two large health facilities in North East Nigeria
por: Itiola, Ademola Joshua, et al.
Publicado: (2019)

The feasibility of preventing mother-to-child transmission of HIV using peer counselors in Zimbabwe
por: Shetty, Avinash K, et al.
Publicado: (2008)

The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis
por: Dunning, Lorna, et al.
Publicado: (2017)

‘We are the advocates for the babies’ - understanding interactions between patients and health care providers during the prevention of mother-to-child transmission of HIV in South Africa: a qualitative study
por: Heerink, Fiona, et al.
Publicado: (2019)

A retrospective analysis of incident pregnancy in phase 1 and 2a HIV-1 vaccine study participants does not support concern for adverse pregnancy or birth outcomes
por: Stranix-Chibanda, Lynda, et al.
Publicado: (2021)

What will it take to bring LAED medication regimens to young people?
por: Hosek, Sybil, et al.
Publicado: (2023)

Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model‐based analysis to inform paediatric HIV screening programmes
por: McCann, Nicole C., et al.
Publicado: (2022)

Do not forget the children: a model‐based analysis on the potential impact of COVID‐19‐associated interruptions in paediatric HIV prevention and care
por: Flanagan, Clare F., et al.
Publicado: (2022)

Validation and Calibration of a Computer Simulation Model of Pediatric HIV Infection
por: Ciaranello, Andrea L., et al.
Publicado: (2013)

Determinants of Tenascin-C and HIV-1 envelope binding and neutralization
por: Mangan, Riley J., et al.
Publicado: (2019)

Anti-homosexual legislation and HIV-related stigma in African nations: what has been the role of PEPFAR?
por: Hagopian, Amy, et al.
Publicado: (2017)

A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa
por: Ramraj, Trisha, et al.
Publicado: (2022)

Wealth-related inequality in early uptake of HIV testing among pregnant women: an analysis of data from a national cross-sectional survey, South Africa
por: Ngandu, Nobubelo Kwanele, et al.
Publicado: (2017)

Systemic administration of a broadly-neutralizing IgG antibody to generate HIV-neutralization responses in breast milk
por: Fouda, GG, et al.
Publicado: (2012)

Enhancing HIV Treatment Access and Outcomes Amongst HIV Infected Children and Adolescents in Resource Limited Settings
por: Goga, Ameena Ebrahim, et al.
Publicado: (2016)

Is elimination of vertical transmission of HIV in high prevalence settings achievable?
por: Goga, Ameena, et al.
Publicado: (2019)

Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials
por: Hompe, Eliza D., et al.
Publicado: (2020)

AIDS Vaccine Research Subcommittee (AVRS) Consultation: Early-Life Immunization Strategies against HIV Acquisition
por: Singh, Anjali, et al.
Publicado: (2019)

Impact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: the national South African Prevention of Mother to Child Evaluation cohort study
por: Ramokolo, Vundli, et al.
Publicado: (2022)

Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure
por: Berendam, Stella J., et al.
Publicado: (2022)

Mixed-methods cross-sectional study of the prevention of vertical HIV transmission program users unaware of male partner’s HIV status, in six South African districts with a high antenatal HIV burden
por: Mmotsa, Tshiamo M., et al.
Publicado: (2023)

Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa
por: Hanass-Hancock, Jill, et al.
Publicado: (2021)

Uptake of care and treatment amongst a national cohort of HIV positive infants diagnosed at primary care level, South Africa
por: Mathivha, Elelwani, et al.
Publicado: (2019)

What Will It Take to Eliminate Pediatric HIV? Reaching WHO Target Rates of Mother-to-Child HIV Transmission in Zimbabwe: A Model-Based Analysis
por: Ciaranello, Andrea L., et al.
Publicado: (2012)

Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa
por: Price, Joan T., et al.
Publicado: (2016)

Isolation of HIV-1-Neutralizing Mucosal Monoclonal Antibodies from Human Colostrum
por: Friedman, James, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g5amtse6d7uuh36k6opr18f7q1